Protein Degradation And Inhibitors

Researchers investigate the complex mechanisms governing protein degradation within cells, focusing on how proteins are targeted for breakdown and the roles these processes play in health and disease. Studies explore the ubiquitin-proteasome system, autophagy, and other cellular pathways responsible for protein turnover. This work involves developing and utilizing advanced molecular biology techniques, biochemical assays, and imaging methods to understand protein homeostasis. Specific areas of interest include identifying novel inhibitors of protein degradation pathways, which can serve as therapeutic agents, and examining how disruptions in these pathways contribute to conditions like cancer, neurodegenerative disorders, and metabolic diseases.

This area of research holds significant relevance for Arkansas’s public health initiatives and its growing biomedical sector. Understanding protein degradation is crucial for developing new treatments for diseases prevalent in the state, including various cancers and age-related conditions. Furthermore, insights gained from this research can inform the development of targeted therapies and diagnostic tools, potentially fostering innovation within Arkansas’s biotechnology and pharmaceutical industries. The focus on cellular mechanisms also aligns with efforts to address health disparities and improve patient outcomes across diverse populations within Arkansas.

This research draws upon and contributes to multiple disciplines, including molecular biology, pharmacology, immunology, and disease mechanisms. Engagement spans multiple Arkansas institutions, fostering collaborative efforts in fundamental biological discovery and the translation of findings into potential clinical applications.